Skip to main content
. 2021 Mar 10;11:5558. doi: 10.1038/s41598-021-84840-3

Table 1.

The characteristics of COVID-19 patients.

ID Age Gender Severity Hospitalized (Y/N) Sampling (Day) Past Medical History Anti-S1 IgG (ng/ml) Inhibition of S/ACE2 Interaction (%)
S1 54 F Mild N 74 N/A 280 55.0
S2 54 M Mild N 72 N/A 1,799 91.2
S3 51 F Mild N 78 N/A 898 87.8
S4 47 F Moderate N 75 Asthma 1,778 90.0
S5 20 F Mild N 77 N/A 1,033 91.1
S6 30 M Moderate N 88 N/A 634 80.0
S7 46 F Moderate N 119 Cardiomyopathy 34 15.0
S8 33 M Mild N 24 Hypertension, HIV 402 66.0
S9 42 F Moderate N 29 N/A 110 33.0
S10 42 M Moderate N 32 N/A 55 36.0
S11 42 F Mild N 17 Hypertension 1,560 86.6
S21 64 F Mild to Moderate N  ~ 60 N/A 56 8.7
S23 19 M Mild to Moderate N  ~ 60 Asthma 96.5
S30 38 M Mild to Moderate N  ~ 60 HIV 55.0